2018
A documentary exploring plant medicines and psychedelics, with an attempt to show a different perspective than the current mainstream narrative. Some of them used for thousands of years as ...
84 min
CLEAR ALL
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.
1
Though researchers are still trying to understand the cognitive and therapeutic mechanics of psychedelics, they have concluded that psilocybin, DMT and other psychoactive chemicals can help people feel more tolerance, understanding and empathy.
2
Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.
The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.
The world’s leading advocate for the medicinal use of psychedelics on the ghost of Timothy Leary, why Ecstasy could cure PTSD, and the best place to trip in Boston.
Rick Doblin founded the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986, as a “non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.”*.
Interview with Rick Doblin, Ph.D. Founder of psychedelic research group MAPS, as he talks about his experience with Ibogaine and LSD, in order to confront his own shadows and be more effective as a political activist.
Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising.
Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.